JAK/STAT: Why choose a classical or an alternative pathway when you can have both?. Issue 7 (3rd March 2022)

• Record Type: Journal Article
• Authors: Puigdevall, Léna; Michiels, Camille; Stewardson, Clara; Dumoutier, Laure
• Is Part Of: Journal of cellular and molecular medicine. Volume 26:Issue 7(2022)
• Page Start: 1865
• Page End: 1875
• Publication Date: 2022-03-03
• Subjects: cytokine signalling -- Janus kinase -- noncanonical -- signal transducer and activator of transcription -- tyrosine‐independent; Cytology; Medicine; Molecular Biology; Cytologie -- Périodiques; Médecine -- Périodiques; Biologie moléculaire -- Périodiques; Cytology -- Periodicals; Medicine -- Periodicals; Molecular biology -- Periodicals; 611.01805
• DOI: 10.1111/jcmm.17168
• Languages: English
• ISSNs: 1582-1838

Abstract

Abstract: A subset of cytokines triggers the JAK‐STAT pathway to exert various functions such as the induction of inflammation and immune responses. The receptors for these cytokines are dimers/trimers of transmembrane proteins devoid of intracellular kinase activity. Instead, they rely on Janus kinases (JAKs) for signal transduction. Classical JAK‐STAT signalling involves phosphorylation of cytokine receptors' intracellular tyrosines, which subsequently serve as docking sites for the recruitment and activation of STATs. However, there is evidence to show that several cytokine receptors also use a noncanonical, receptor tyrosine‐independent path to induce activation of STAT proteins. We identified two main alternative modes of STAT activation. The first involves an association between a tyrosine‐free region of the cytokine receptor and STATs, while the second seems to depend on a direct interaction between JAK and STAT proteins. We were able to identify the use of noncanonical mechanisms by almost a dozen cytokine receptors, suggesting they have some importance. These alternative pathways and the receptors that employ them are discussed in this review.